Welcome to the e-CCO Library!

P410 Could the disease become ‘a friend’? The mediating role of illness acceptance on self-efficacy and quality of life of gastroenterological patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Rudnik1,2, G. Piotrowicz2, G. Rydzewska3,4, M. Bidzan1, E. Ozgo5

Created: Thursday, 30 January 2020, 10:12 AM
P410: Extraintestinal manifestations and quality of life in patients with ulcerative colitis: 1-year data from ICONIC
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Ghosh*1, F. Casellas2, C. O’Shea3, M. Leonard3, J. Petersson4, L. Peyrin-Biroulet5

Created: Friday, 22 February 2019, 9:41 AM
P410: Has body composition any effect on thiopurine level in IBD?
Year: 2018
Source: ECCO '18 Vienna
Authors:

Á. Milassin1*, K. Szántó1, A. Fábián1, R. Bor1, K. Farkas1, A. Bálint1, M. Rutka1, I. Földesi2, A.L. Szijártó3, Z.A. Mezei4, T. Bubán5, F. Nagy1, Z. Szepes1, T. Molnár1, K. Palatka6

Created: Thursday, 21 February 2019, 9:14 AM
P410: Long-term persistence and safety of biological drugs in patients with Inflammatory Bowel Disease. Differences between women and men: SEXEII study of ENEIDA
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gargallo-Puyuelo, C.(1)*;Ricard, E.(2);Iborra, M.(3);Iglesias-Flores, E.(4);Vera Mendoza, I.(5);De Francisco García, R.(6);Calafat Sard, M.(7);Minguez, M.(8);Lopez- San Roman, A.(9);Taxonera, C.(10);Guardiola, J.(11);Barrio, J.(12);Laredo, V.(13);De Castro, L.(14);Gisbert, J.(15);García-Lopez, S.(16);García Planella, E.(17);Martín Arranz, D.(18);Calvet, X.(19);Merino, O.(20);Sierra, M.(21);Marquez, L.(22);Madero, L.(23);Varela, P.(24);Carpio, D.(25);Esteve, M.(26);Rivero, M.(27);Ramos , L.(28);Sicilia, B.(29);Lorente POyatos, R.(30);Marin, I.(31);Monfort, D.(32);Navarro, M.(33);VEga, P.(34);Hinojosa, J.(35);Tardillo, C.(36);García Sepulcre, M.F.(37);Barreiro, M.(38);Domenech, E.(7);Gomollón, F.(39);
Created: Friday, 14 July 2023, 11:05 AM
P410: safety of biological drugs for inflammatory bowel disease in elderly patients
Year: 2022
Source: ECCO'22
Authors: Suarez Ferrer, C.J.(1);Mesonero, F.(2);Caballol, B.(3);Ballester, M.P.(4);Baston Rey, I.(5);Castaño Garcia, A.(6);Miranda Bautista, J.(7);Saiz Chumillas, R.(8);Benitez , J.M.(9);Sanchez Delgado, L.(10);Lopez-Garcia, A.(11);Rubin de Celix, C.(12);Lopez Sanroma, A.(2);Martin-Arranz, M.D.(13);Fernández-Clotet , A.(3);Merino Murgui , V.(14);Calviño Suárez , C.(15);Florez, P.(16);Lobato matilla, M.E.(7);Sicilia, B.(17);Soto Escribano, P.(18);Maroto Martin , C.(10);Alonso Abreu, I.(19);Melcarne, L.(20);Plaza Santos, R.(21);Marques Cami, M.(22);Caballero Mateos , A.(23);Gómez Díez , C.(24);Calafat, M.(25);Alonso Galan, H.(26);Vega Villaamil , P.(27);Castro Senosiain , B.(28);Guerro Moya , A.(29);Rodriguez Diaz , C.Y.(30);Spicakova, K.(31);Manceñido Marcos, N.(32);Molina, G.(33);De Castro, L.(34);Mañosa Ciria , M.(25);Barreiro-De Acosta , M.(15);
Created: Friday, 11 February 2022, 3:52 PM
P410: Segmental endoscopic scoring improves outcome prediction in acute severe colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Raimundo Fernandes*, P. Santos, C. Moura, P. Marques da Costa, J. Rita Carvalho, C. Baldaia, A. Valente, A. Rita Gonçalves, P. Moura Santos, L. Correia, J. Velosa

Created: Friday, 22 February 2019, 9:49 AM
P410: Vedolizumab is safe and effective for IBD, but has no effect on liver biochemistry in patients with concurrent PSC
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Christensen B.*1, Micic D.2, Gibson P.R.1, Singh S.3, Bellaguarda E.2, Corsello P.4, Gaetano J.N.5, Kinnucan J.4, Rao V.L.5, Reddy S.2, Yarur A.3, Rubin D.T.5, Pekow J.5

Created: Wednesday, 20 February 2019, 10:36 AM
P410: Which patients with established Crohn's disease benefit most from the use of the Patency capsule test prior to small bowel capsule endoscopy?
Year: 2021
Source: ECCO'21 Virtual
Authors: Elosua Gonzalez, A.(1);Rullan Iriarte, M.(1);Rubio Iturria, S.(2);Rodríguez Gutiérrez, C.(2);Vicuña Arregui, M.(2);Elizalde Apesteguía, I.(2);Aznárez Barrio, M.R.(2);Juanmartiñena Fernández, J.F.(2);Nantes Castillejo, Ó.(2);Fernández-Urién, I.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P411 Faecal calprotectin is more tightly associated with endoscopic disease activity compared with other biomarkers in patients with inflammatory bowel disease under maintenance treatment with adalimumab
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Orfanoudaki, E. Theodoraki, K. Foteinogianopoulou, A. Mantaka, I. Koutroubakis

Created: Thursday, 30 January 2020, 10:12 AM
P411: Baseline Hypertrophy of the Submucosa at intestinal ultrasound predicts Failure of Treatment in patients with ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: de Voogd, F.(1);Duijvestein, M.(1);Ponsioen, C.(1);Löwenberg, M.(1);D'Haens, G.(1);Gecse, K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P411: Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease centre: Accessibility, resource utilisation and outcomes
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Restellini1,2*, I. Morin1, Z. Kurti3, T. Bessissow1, W. Afif1, G. Wild1, E. Seidman1, A. Bitton1, P.L. Lakatos1,3

Created: Thursday, 21 February 2019, 9:14 AM
P411: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kurti Z.*1, Rutka M.2, Vegh Z.1, Gonczi L.1, Farkas K.2, Lovasz B.D.1, Gecse K.B.1, Golovics P.A.1, Szalay B.3, Molnar T.2, Lakatos P.L.1

Created: Wednesday, 20 February 2019, 10:36 AM
P411: Early ultrasound assessment predicts therapy response: an easy tool for clinical decision making
Year: 2023
Source: ECCO’23 Copenhagen
Authors: CalabresePhD, E.(1)*;Castiglione, F.(2);De Cristofaro, E.(1);Rispo, A.(2);Capacchione , C.(1);Testa, A.(2);Guarino, A.D.(2);Caiazzo, A.(2);Monteleone, G.(1);Zorzi, F.(1);
Created: Friday, 14 July 2023, 11:05 AM
P411: Four-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Cassieri*1, R. Pica1, E. v. V. Avallone1, G. Brandimarte2, M. Zippi1, P. Crispino1, G. Lecca2, C. Corrado1, P. Vernia1, P. Paoluzi1, E. v. S. Corazziari1

Created: Friday, 22 February 2019, 9:49 AM
P411: Stable pharmacokinetics and biochemical markers of inflammatory bowel disease activity: Results from a real-world adalimumab biosimilar switching program
Year: 2022
Source: ECCO'22
Authors: Moore, A.C.(1);Russell, D.(1);Dart, R.(1,2);Dias, S.(1);Ghuman, S.(1);Petri, B.(1);Sharma, E.(1);Ray, S.(1);Anderson, S.(1);Mawdsley, J.(1);Irving, P.M.(1);Samaan, M.A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P411: Using wearable devices to assess pain in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

O. V. Yvellez*1, P. H. Sossenheimer1, M. Andersen Jr1, K. El Jurdi1, A. Mayampurath2, D. T. Rubin1

Created: Friday, 22 February 2019, 9:41 AM
P412 Maintenance therapy of vedolizumab (VDZ) after induction of remission by tacrolimus (TAC) in patients with refractory ulcerative colitis (UC)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Ito, M. Shun, O. Teppei, T. Katsutoshi

Created: Thursday, 30 January 2020, 10:12 AM
P412: Drug persistence and endoscopic, histologic and biochemical remission rates among patients following ileal pouch-anal anastomosis treated with biologic therapy: Results from a prospective patient cohort.
Year: 2022
Source: ECCO'22
Authors: Ollech, J.(1);Yanai, H.(1);Avni-Biron, I.(1);Snir, Y.(1);Banai, H.(1);Broitman, Y.(1);Goren, I.(1);Wasserberg, N.(2);White, I.(2);Dotan, I.(1);
Created: Friday, 11 February 2022, 3:52 PM
P412: Effectiveness of ustekinumab in fistulising perianal Crohn´s disease refractory or intolerant to anti-TNF
Year: 2021
Source: ECCO'21 Virtual
Authors: Carpio, D.(1);Calviño-Suarez , C.(2);Martínez-Cadilla , J.(3);Molina , G.(4);Vázquez-Rey , M.T.(5);Martí , E.(6);Fernández-Salgado , E.(1);Barreiro-de Acosta , M.(2);Hernández , V.(3);Echarri , A.(4);Diz-Lois , M.T.(5);Baz , A.(6);
Created: Wednesday, 2 June 2021, 4:12 PM
P412: Efficacy and safety of additional autologous platelet-rich stroma in transanal mucosal advancement flap repair of complex cryptoglandular anal fistulas
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Arkenbosch*1, O. van Ruler2, W. Deijl2, J. Stevens3, A. de Vries4, J. van der Woude4, E. de Graaf2, R. Schouten1,2

Created: Friday, 22 February 2019, 9:41 AM